RNS Number : 1573A
Plant Health Care PLC
25 September 2015
25 September 2015
PLANT HEALTH CARE plc
("Plant Health Care" or the "Company")
Plant Health Care Signs Third and Fourth Innatus™ 3G Agreements
Company Expanding R&D Capabilities and Expertise
Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today announced that it has signed its third and fourth agreements with major industry players in the agricultural space regarding the evaluation of its Innatus™ 3G peptide platform. This technology platform enables the design, production and screening of a large pipeline of peptides with diverse biological properties. The peptides can be used for both seed treatment and foliar applications. They can also be combined with conventional crop protection chemicals, making them highly complementary to existing production practices.
To enhance and accelerate the Company's unique capabilities in the field of PREtec science (Plant Response Elicitor technology), the Company has moved its Seattle-based research facility to a significantly larger installation, expanding its footprint to over four times its previous size. Furthermore, Plant Health Care has made two notable additions to its staff. The company recently hired Dr. Mariola Kopcinski as Director, Scientific Alliances. In this role, Dr. Kopcinski will be responsible for identifying technology in and out licensing opportunities and managing relationships with potential licensors and licensees. Dr. Kopcinski brings to PHC an extensive background in various research, product management and marketing roles. Most recently, she was the Global Strategic Marketing Director at FMC. Previously, Dr. Kopcinski held management positions at Syngenta, Valent BioSciences, DuPont and Rohm and Haas. She holds an MBA from the University of Rochester and a Ph.D. in Agriculture from Akademia Rolnicza im. Augusta Cieszkowskiego w Poznaniu.
Plant Health Care has also hired Dr. Guofu Li as a senior scientist. Most recently, he was a research scientist at DuPont Pioneer, formally Pioneer Hi-Bred. Previously, Dr. Li was with Sangamo BioSciences. He holds an MS in Agronomy from the University of the Philippines and a Ph.D. in Biology from Texas A&M University.
Paul Schmidt, CEO of Plant Health Care, commented, "Our continuing success in signing up major industry players to evaluate our Innatus 3G platform is a strong validation of the potential benefit our customers believe this technology can bring to the agricultural market. As we move forward with these evaluation agreements, we are continuing to build the development capability and expertise to support the expansion and eventual commercialization of this technology. The combination of expanding our R&D capabilities and adding key personnel like Dr. Kopcinski and Dr. Li to the team bolsters our position as a leading player in this market sector."
- ENDS -
For further information, please contact:
Plant Health Care plc
Paul Schmidt, Chief Executive Officer Tel: +1 (919) 926 1600
Liberum Capital - Nomad and Broker
Clayton Bush Tel: +44 (0) 20 3100 2000
Ed McGregor / Jody Burfening Tel: +1 (212) 838 3777
Company website: www.planthealthcare.com
About Plant Health Care: Plant Health Care is a leading provider of novel patent-protected biological products to the global agriculture markets. In this way, Plant Health Care is capitalising on long-term trends toward natural systems and biological products for plant care and soil and water management. The Company's ordinary shares have been quoted on the AIM market of the London Stock Exchange since July 2004 (ticker symbol: PHC).
This information is provided by RNS
The company news service from the London Stock Exchange